<PAGE>
                                 UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            
                            Washington, D.C. 20549
                             --------------------

                                   FORM 10-Q


[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
             SECURITIES EXCHANGE ACT OF 1934

                    For the quarter ended November 29, 1997


[  ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
             SECURITIES EXCHANGE ACT OF 1934


                        SUBURBAN OSTOMY SUPPLY CO., INC.
            
        
        
        MASSACHUSETTS                      5047                  04-2675674
(State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer
incorporation or organization)  Classification Code Number) Identification No)


                              75 OCTOBER HILL ROAD
                              HOLLISTON, MA 01746
                                (508) 429-1000


Securities registered pursuant to Section 12(b) of the Act: NONE

Securities registered pursuant to Section 12 (g) of the Act:

         Title of each class       Name of each exchange on which registered
         -------------------       -----------------------------------------
     Common Stock, no par value                     NASDAQ


          Indicate by check mark whether the registrant: (1) has filed all
reports required to be filed by Section 13 or 15 (d) of the Securities Exchange
Act of 1934 during the preceding 12 months and (2) has been subject to such
filing requirements for the past 90 days.      Yes [ ]          No [X]

          Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-Q or any
amendment to this Form 10-Q.  [X]

          Indicate the number of shares outstanding of each of the issuer's
classes of common stock as of the last practical date.  As of December 31, 1997
there were 10,538,622 shares of the Registrant's Common Stock outstanding.
<PAGE>
<PAGE>                               PART I
ITEM 1.   FINANCIAL STATEMENTS

                       SUBURBAN OSTOMY SUPPLY CO., INC.
                          CONSOLIDATED BALANCE SHEETS
                            (Dollars in thousands)
<TABLE>
<CAPTION>
                                        NOVEMBER 29, 1997  AUGUST 30, 1997
                                        _________________  _______________
                                            (unaudited)
<S>                                            <C>           <C>
                                    ASSETS
Current Assets
 Cash and cash equivalents                     $ 2,202       $ 2,270
 Accounts receivable, less allowances       
     of $729 and $638                           12,748        12,207
 Merchandise inventory                           8,140         6,611
 Prepaid expenses and other current assets         518           332
 Deferred income taxes                             516           464
                                                ______        ______
     Total current assets                       24,124        21,884
      
 Fixed assets, net                               1,883         1,651
 Goodwill                                       19,166        17,312
 Other long-term assets                            139           277
                                                ______        ______
     Total assets                              $45,312       $41,124
                                                ======        ======  
 
                     LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities:
 Current portion of long-term debt             $    --       $    16
 Accounts payable and accrued expenses           8,692         7,608
                                                ______        ______
     Total current liabilities                   8,692         7,624
                             
Long-term Liabilities:
 Long-term debt, less current portion               --             7
 Bank line of credit                             2,000            --
 Deferred income taxes                              35            21
                                                 _____        ______
                                                 2,035            28
Stockholders' Equity:
 Common Stock, no par; 40,000,000 shares  
   authorized; issued and outstanding - 
   10,538,622 and 10,538,503 shares             47,188        47,188
 Accumulated deficit                           (12,603)      (13,716)
                                                ______        ______
     Total stockholders' equity                 34,585        33,472
                                                ______        ______
Total liabilities and stockholders' equity     $45,312       $41,124
                                                ======        ======
</TABLE>
The accompanying notes are an integral part of these consolidated financial 
statements.
                                       2<PAGE>
<PAGE>                 SUBURBAN OSTOMY SUPPLY CO., INC.
                       CONSOLIDATED STATEMENTS OF INCOME
               (Dollars in thousands, except per share amounts)
                                  (unaudited)
<TABLE>
<CAPTION>
                                                   THREE MONTHS ENDED      
                                         NOVEMBER 29, 1997  NOVEMBER 30, 1996 
                                         _________________  _________________ 
<S>                                           <C>               <C>           
Net sales                                     $27,490           $21,963       
Cost of goods sold                             19,853            16,845        
                                               ______            ______        
    Gross margin                                7,637             5,118         

Operating expenses                              5,160             2,797          
Depreciation and amortization                     359               213            
                                               ______            ______
    Operating income                            2,118             2,108         

Interest income                                    50                73            
Interest expense                                  (64)             (415)            
Other (expense) income                            (22)              (26)            
                                               ______            ______
    Income before income taxes                  2,082             1,740         

Provision for income taxes                        969               769          
                                               ______            ______
    Net income                                  1,113               971          

Accretion of Preferred Stock                       --               101            
    
    Net income applicable to common            ______            ______        
      stockholders                            $ 1,113           $   870        
                                               ======            ======
    
    Net income per share                      $  0.10
                                               ======
    Weighted average common shares               
      outstanding                              11,189   
__________________________________
Supplemental Pro Forma (see Note 2):                             

    Net income                                    n/a           $ 1,231        
                                                                 ======          
    Net income per share                          n/a              $.11          
                                                                   ====           
    Weighted average common shares               
      outstanding                                                10,919        
                                               
</TABLE>
The accompanying notes are an integral part of these consolidated financial 
statements.
                                       3<PAGE>
<PAGE>
                       SUBURBAN OSTOMY SUPPLY CO., INC.
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                            (Dollars in thousands)
                                  (unaudited)
<TABLE>
<CAPTION>                                            THREE MONTHS ENDED 
                                                 NOVEMBER 29,   NOVEMBER 30, 
                                                    1997           1996
                                                 ____________   ___________
<S>                                                <C>            <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income                                         $ 1,113        $  971         
Adjustments to reconcile net income to cash
 from operating activities:
   Depreciation and amortization                       359           213
 Changes in assets and liabilities, net
  of effects from acquisition of Care Management
   Accounts receivable                                 647           841
   Merchandise inventory                              (850)         (266)
   Prepaid expenses and other                         (108)          170
   Accounts payable and accrued expenses               134          (390)
                                                     _____         _____ 
Net cash from operating activities                   1,295         1,539

CASH FLOWS (USED BY) FROM INVESTING ACTIVITIES:
  Purchase of fixed assets                            (133)          (13)
  Purchase of Care Management, 
     net of cash acquired                           (3,134)           --
  Other assets and goodwill                            (73)           49
                                                    ______         _____
Net cash used by investing activities               (3,340)           36
 
CASH FLOWS FROM FINANCING ACTIVITIES:
  Net borrowing under line of credit                 2,000            --
  Issuance of common stock, net of
    issuance costs                                      --        46,016
  Retirement of preferred stock                         --        (7,538)  
  Repayments of long-term bank debt, net               (23)      (24,449)
  Repayments of subordinated debt                       --       (10,485)   
                                                    ______        ______ 
Net cash from financing activities                   1,977         3,544

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS   (68)        5,119
 
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD       2,270         1,995
                                                    ______        ______   
CASH AND CASH EQUIVALENTS, END OF PERIOD           $ 2,202       $ 7,114
                                                    ======        ======
</TABLE>

The accompanying notes are an integral part of these consolidated financial 
statements.
                                       4<PAGE>
<PAGE>
                      SUBURBAN OSTOMY SUPPLY COMPANY INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(1)  BASIS OF PRESENTATION

     The accompanying unaudited consolidated financial statements have been
     prepared in accordance with generally accepted accounting principles for
     interim financial information and with the instructions to Form 10-Q and
     Article 10 of Regulation S-X. Accordingly, they do not include all the
     information and footnotes required by generally accepted accounting prin-
     ciples for complete financial statements. In the opinion of management,
     all adjustments considered necessary for a fair presentation of the fi-
     nancial statements, primarily consisting of normal recurring adjustments,
     have been included. Operating results for the three months ended November
     29, 1997 are not necessarily indicative of the results that may be ex-
     pected for the year ending August 29, 1998 or any other interim period.

     These statements should be read in conjunction with the consolidated
     financial statements, notes and other information included in the Company's
     latest Form 10-K.  Certain reclassifications have been made to the 1997 
     consolidated financial statements to conform to the 1998 presentation.

(2)  SUPPLEMENTAL PRO FORMA NET INCOME PER SHARE

     Supplemental pro forma net income per share for the three months ended 
     November 30, 1996 has been calculated, as if as of September 3, 1995, 
     the Company had sold the 3.9 million shares of Common Stock sufficient 
     to fund the July 3, 1995 Recapitalization and repay indebtedness incurred 
     to finance two acquisitions.

     The weighted average number of shares is the actual weighted average number
     of shares of Common Stock or equivalents thereof outstanding plus the 3.9
     million shares of Common Stock that were sold in connection with the public
     offering, assuming issuance occurred on September 3, 1995.  For the period
     subsequent to October 15, 1996, weighted average shares reflect actual
     weighted average shares computed consistent with the treasury stock method.

                                                  QUARTER ENDED
                                                NOVEMBER 30, 1996      
     (in thousands, except per share amounts)   _________________

     Historical income before taxes                   $1,740
     Provision for income taxes                         (769)
     Reversal of interest charges and amorti-
      zation of deferred financing costs relating 
      to debt treated as being repaid, net of tax        260      
                                                       _____    
     Supplemental pro forma net income                $1,231
                                                      ======
     Supplemental pro forma net income per
                 share                                $  .11
                                                      ======
     Supplemental pro forma weighted average
      shares outstanding                              10,919           
                                       5<PAGE>
<PAGE>
                      SUBURBAN OSTOMY SUPPLY COMPANY INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(3)  RECENT ACCOUNTING PRONOUNCEMENT

     In February 1997, the Financial Accounting Standards Board issued
     Statement of Financial Accounting Standards No. 128, Earnings Per Share
     (SFAS 128).  This Statement establishes standards for computing and
     presenting earnings per share and applies to entities with publicly 
     traded common stock or potential common stock.  SFAS 128 is effective 
     for financial statements for both interim and annual periods ending 
     after December 15, 1997 and early adoption is not permitted.  When adopt-
     ed, the statement will require restatement of prior years' earnings per 
     share.  The Company will adopt this statement for its quarter ended Feb-
     ruary 28, 1998.  Assuming that SFAS 128 had been implemented, basic 
     earnings per share would have been $0.11 and $0.12 for the three month 
     periods ended November 29, 1997 and November 30, 1996, respectively.  
     Under this Statement, diluted earnings per share would not have differed 
     from the net income per share disclosed on the income statement.

(4)  ACQUISITION OF CARE MANAGEMENT

     On October 10, 1997, Suburban Ostomy acquired all the outstanding 
     capital stock of Care Management, a medical supply management company, 
     for an aggregate consideration of approximately $3.1 million in cash.  
     The cost of the acquisition exceeded the estimated fair market value of 
     the net assets acquired by approximately $1.9 million, which has been 
     included on the Consolidated Balance Sheet under goodwill.  The Company 
     has accounted for the transaction as a purchase and the Consolidated 
     Income Statement includes Care Management's results from October 10, 
     1997 through November 29, 1997.    
                                       
(5)  SUBSEQUENT EVENT

     On December 17, 1997, Invacare of Ohio announced a tender offer for all 
     the outstanding common stock of Suburban Ostomy.  The offer of $11.75 per 
     common share has been agreed to by management and a majority of Company
     stockholders.  The effective date of the purchase is expected to be 
     January 31, 1998, at which time Suburban Ostomy will become a wholly 
     owned subsidiary of Invacare.

                                       6<PAGE>
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
        RESULTS OF OPERATIONS

ACQUISITION

     On October 10, 1997, Suburban Ostomy acquired all of the outstanding 
stock of Care Management for approximately $3.1 million in cash. The trans-
action was accounted for as a purchase, and the consolidated income statements 
include the results of Care Management's operations from October 10, 1997 
(See Note 4).  
     

RESULTS OF OPERATIONS 

Quarter ended November 29, 1997 versus November 30, 1996

     Net sales increased by $5.5 million, or 25%, to $27.5 million for the
quarter ended November 29, 1997 versus $22.0 million for the prior year 
period due primarily to incremental volume from Peiser's (acquired on May 1, 
1997) and Care Management.  The number of customer orders filled increased 
35,640 to approximately 161,140 orders for the quarter ended November 29, 
1997 versus approximately 125,500 for the prior year period. The average 
order size decreased to $176 for the quarter ended November 29, 1997 versus 
$180 for the prior year period due primarily to the addition of Peiser's 
patient-specific home health agency business which has a smaller average 
order size than Suburban Ostomy's business.

     Gross margin increased by $2.5 million, or 49%, to $7.6 million for the
quarter ended November 29, 1997 versus $5.1 million for the prior year period.
Gross margin increased to 27.8% versus 23.3% for the prior year period. The
increase in gross margin was due primarily to the additional volume from 
Peiser's and Care Management.  The increase in gross margin as a percentage of 
sales was due primarily to Peiser's home health agency business, which has
higher gross margins than Suburban's historical business.

     Operating expenses increased by $2.4 million, or 84%, to $5.2 million for
the quarter ended November 29, 1997 versus $2.8 million for the prior year
period, and as a percentage of net sales, increased to 18.8% versus 12.7% for
the prior period.  The increase in operating expenses as a percentage of net
sales was due primarily to the the recent acquisitions of Peiser's and Care 
Management, which have traditionally had higher operating costs.

     Depreciation and amortization expense increased by $146,000, or 68.5%, to 
$359,000 for the quarter ended November 29, 1997 versus $213,000 for the prior 
year period due primarily to an increase in the amortization of goodwill 
associated with acquisitions.

     Operating income remained constant at $2.1 million for the quarters ended
November 29, 1997 and November 30, 1996.  However, as a percentage of net 
sales, operating income decreased to 8% for the quarter ended November 29, 
1997 versus 10% for the prior year period due primarily to the higher 
operating costs at the two recent acquisitions.

                                       7<PAGE>
<PAGE>
     Interest expense decreased by $351,000, or 85%, to $64,000 for the quarter 
ended November 29, 1997 versus $415,000 for the prior year period due primarily 
to the repayment of substantially all long-term debt from the proceeds of the 
initial public offering in October 1996.

     The provision for income taxes was $969,000, an effective tax rate of 
46.5% of pre-tax income, for the quarter ended November 29, 1997 versus 
$769,000, or an effective tax rate of 44.2%, for the quarter ended November 
30, 1996.  The increase is due primarily to higher state tax liabilities.


LIQUIDITY AND CAPITAL RESOURCES

Borrowing capacity under the Company's Credit Facility (the "Credit Facility")
is $30 million, and borrowings bear interest at either its lender's Base Rate 
or LIBOR plus an applicable margin, depending on the Company's earnings.  The
outstanding borrowings under the Credit Facility are secured by substantially
all of the assets of the Company, including a pledge of all of the capital
stock of its subsidiaries. The Credit Facility contains covenants which
require the Company to maintain certain financial ratios and impose certain
limitations and prohibitions on the Company with respect to: (i) incurring
additional indebtedness; (ii) the creation of security interests on the assets
of the Company; and (iii) the payment of cash dividends on the Common Stock.
At November 29, 1997, the Company was in compliance with such covenants. The
Company borrowed $3 million on October 10, 1997 for the purpose of acquiring
Care Management (see Note 4). There was $2 million outstanding under the Credit 
Facility at November 29, 1997.

The Company's long-term liquidity needs consist of working capital and capital 
required to fund future acquisitions. The Company believes that its cash flow 
from operations and its Credit Facility will be sufficient to fund its 
operations and possible acquisitions through fiscal 1998.

Forward-looking statements in this report, including without limitation,
statements relating to the Company's plans, strategies, objectives, 
expectations, intentions and adequacy of resources, are made pursuant to the 
safe harbor provisions of the Private Securities Litigation Reform Act of 1996.
Investors are cautioned that such forward-looking statements involve risks and
uncertainties, including without limitation the following: (i) the Company's
plans, strategies, objectives, expectations and intentions are subject to change
at any time at the discretion of the Company; (ii) the Compnay's plans and
results of operations will be affected by the Company's ability to manage its
growth; and (iii) other risks and uncertainties indicated from time to time in
the Company's filings with the Securities and Exchange Commission.


SUBSEQUENT EVENT

On December 17, 1997, Invacare of Ohio announced a tender offer for all the
outstanding common stock of Suburban Ostomy. The offer of $11.75 per share has
been agreed to by management and a majority of stockholders. The effective date
of the purchase is expected to be January 31, 1998, at which time Suburban 
Ostomy would become a wholly-owned subsidiary of Invacare (see Note 5).

                                       8<PAGE>
<PAGE>
 
                                    PART II

ITEM 1. LEGAL PROCEEDINGS

        The Company is party to certain claims and litigation in the ordinary 
        course of business. The Company is not involved in any legal proceed-
        ing that it believes will result, individually or in the aggregate, 
        in a material adverse effect on its financial condition or results 
        of operations.

ITEM 2. CHANGES IN SECURITIES - None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES - None

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS - None

ITEM 5. OTHER INFORMATION - None

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

     (a) Exhibits

         Exhibit 27 - Financial Data Schedule

     (b) Reports on Form 8-K
 
         None
           
 
                                  SIGNATURES

     Pursuant to the requirements of the section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed 
on its behalf by the undersigned, thereunto duly authorized.


January 9, 1998
                        /s/ Donald H. Benovitz
                    By:________________________________
                       Donald H. Benovitz
                       President and Director

January 9, 1998
                        /s/ Stephen N. Aschettino
                    By:________________________________
                       Stephen N. Aschettino
                       Vice President, Chief Financial Officer and Treasurer
                       (Principal Financial and Accounting Officer)


                                       9<PAGE>